Clinical effect of successful reperfusion in patients presenting with NIHSS < 8: data from the BEYOND-SWIFT registry

Autor: Jan Gralla, Christoph C. Kurmann, Steven D. Hajdu, Benjamin Friedrich, Matthias Gawlitza, Johannes Kaesmacher, Amel Benali, Patrik Michel, Leonidas Panos, Marc Ribo, Christian Maegerlein, Manuel Requena, Mirjam Rachel Heldner, Laurent Pierot, Urs Fischer, Joanna D. Schaafsma, Pasquale Mordasini, Vincent Costalat, Panagiotis Chaloulos-Iakovidis, Vitor Mendes Pereira
Přispěvatelé: Inselspital Bern, Bern University Hospital [Berne] (Inselspital), Service of Neurology [CHUV, Lausanne, Switzerland], Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Vall d'Hebron University Hospital [Barcelona], Klinikums rechts der Isar, Département de Neuroradiologie[Montpellier], Hôpital Gui de Chauliac [Montpellier]-Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Université Montpellier 1 (UM1)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Universitaire de Reims (CHU Reims), Toronto Western Hospital
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
Neurology
[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging
medicine.medical_treatment
Low NIHSS
Severity of Illness Index
0302 clinical medicine
Modified Rankin Scale
Outcome Assessment
Health Care
030212 general & internal medicine
Registries
610 Medicine & health
Stroke
Neuroradiology
Aged
80 and over
Aged
Female
Fibrinolytic Agents/therapeutic use
Follow-Up Studies
Humans
Magnetic Resonance Imaging
Mechanical Thrombolysis/methods
Middle Aged
Outcome Assessment (Health Care)
Reperfusion/methods
Retrospective Studies
Stroke/diagnosis
Stroke/diagnostic imaging
Stroke/therapy
Endovascular
Mechanical thrombectomy
Mild symptoms
Thrombolysis
Original Communication
Cerebral infarction
3. Good health
ddc
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
medicine.medical_specialty
Mechanical Thrombolysis
MESH: Fibrinolytic Agents / therapeutic use
Outcome assessment
Health Care
Reperfusion / methods
Stroke / therapy
03 medical and health sciences
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
Fibrinolytic Agents
Internal medicine
medicine
cardiovascular diseases
business.industry
Odds ratio
medicine.disease
Confidence interval
nervous system diseases
Reperfusion
Neurology (clinical)
business
030217 neurology & neurosurgery
Zdroj: Journal of neurology, vol. 266, no. 3, pp. 598-608
Journal of Neurology
Kaesmacher, Johannes; Chaloulos-Iakovidis, Panagiotis; Panos, Leonidas; Mordasini, Pasquale; Heldner, Mirjam Rachel; Kurmann, Christoph C.; Michel, P.; Hajdu, S. D.; Ribo, M.; Requena, M.; Maegerlein, C.; Friedrich, B.; Costalat, V.; Benali, A.; Pierot, L.; Gawlitza, M.; Schaafsma, J.; Pereira, V. M.; Gralla, Jan and Fischer, Urs (2019). Clinical effect of successful reperfusion in patients presenting with NIHSS < 8: data from the BEYOND-SWIFT registry. Journal of neurology, 266(3), pp. 598-608. Springer-Medizin-Verlag 10.1007/s00415-018-09172-1
Journal of Neurology, Springer Verlag, 2019, 266 (3), pp.598-608. ⟨10.1007/s00415-018-09172-1⟩
ISSN: 0340-5354
1432-1459
DOI: 10.1007/s00415-018-09172-1
Popis: Background and purpose If patients presenting with large vessel occlusions (LVO) and mild symptoms should be treated with endvoascular treatment (EVT) remains unclear. Aims of this study were (1) assessing the safety and technical efficacy of EVT in patients with NIHSS
Databáze: OpenAIRE
Externí odkaz: